118 related articles for article (PubMed ID: 17266640)
1. Recent advances in the development of agonists selective for beta1-type thyroid hormone receptor.
Malm J; Grover GJ; Färnegårdh M
Mini Rev Med Chem; 2007 Jan; 7(1):79-86. PubMed ID: 17266640
[TBL] [Abstract][Full Text] [Related]
2. Thyroid receptor ligands. 1. Agonist ligands selective for the thyroid receptor beta1.
Ye L; Li YL; Mellström K; Mellin C; Bladh LG; Koehler K; Garg N; Garcia Collazo AM; Litten C; Husman B; Persson K; Ljunggren J; Grover G; Sleph PG; George R; Malm J
J Med Chem; 2003 Apr; 46(9):1580-8. PubMed ID: 12699376
[TBL] [Abstract][Full Text] [Related]
3. Thyroid hormone ligands and metabolic diseases.
Malm J
Curr Pharm Des; 2004; 10(28):3525-32. PubMed ID: 15579049
[TBL] [Abstract][Full Text] [Related]
4. Design and synthesis of a novel series of [1-(4-hydroxy-benzyl)-1H-indol-5-yloxy]-acetic acid compounds as potent, selective, thyroid hormone receptor β agonists.
Burkholder TP; Cunningham BE; Clayton JR; Lander PA; Brown ML; Doti RA; Durst GL; Montrose-Rafizadeh C; King C; Osborne HE; Amos RM; Zink RW; Stramm LE; Burris TP; Cardona G; Konkol DL; Reidy C; Christe ME; Genin MJ
Bioorg Med Chem Lett; 2015 Apr; 25(7):1377-80. PubMed ID: 25752984
[TBL] [Abstract][Full Text] [Related]
5. Thyroid receptor ligands. Part 5: novel bicyclic agonist ligands selective for the thyroid hormone receptor beta.
Garcia Collazo AM; Koehler KF; Garg N; Färnegårdh M; Husman B; Ye L; Ljunggren J; Mellström K; Sandberg J; Grynfarb M; Ahola H; Malm J
Bioorg Med Chem Lett; 2006 Mar; 16(5):1240-4. PubMed ID: 16338239
[TBL] [Abstract][Full Text] [Related]
6. Structure-based approach for the study of thyroid hormone receptor binding affinity and subtype selectivity.
Wang FF; Yang W; Shi YH; Cheng XR; Le GW
J Biomol Struct Dyn; 2016 Oct; 34(10):2251-67. PubMed ID: 26510472
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic potential for thyroid hormone receptor-beta selective agonists for treating obesity, hyperlipidemia and diabetes.
Grover GJ; Mellström K; Malm J
Curr Vasc Pharmacol; 2007 Apr; 5(2):141-54. PubMed ID: 17430219
[TBL] [Abstract][Full Text] [Related]
8. Development of the thyroid hormone receptor beta-subtype agonist KB-141: a strategy for body weight reduction and lipid lowering with minimal cardiac side effects.
Grover GJ; Mellstrom K; Malm J
Cardiovasc Drug Rev; 2005; 23(2):133-48. PubMed ID: 16007230
[TBL] [Abstract][Full Text] [Related]
9. 3D-QSAR and molecular docking studies of selective agonists for the thyroid hormone receptor beta.
Du J; Qin J; Liu H; Yao X
J Mol Graph Model; 2008 Sep; 27(2):95-104. PubMed ID: 18436460
[TBL] [Abstract][Full Text] [Related]
10. Design, synthesis, and structure-activity relationship (SAR) of N-[7-(4-hydroxyphenoxy)-6-methylindan-4-yl]malonamic acids as thyroid hormone receptor β (TRβ) selective agonists.
Shiohara H; Nakamura T; Kikuchi N; Ozawa T; Matsuzawa A; Nagano R; Ohnota H; Miyamoto T; Ichikawa K; Hashizume K
Bioorg Med Chem; 2013 Feb; 21(3):592-607. PubMed ID: 23276448
[TBL] [Abstract][Full Text] [Related]
11. Discovery of novel indane derivatives as liver-selective thyroid hormone receptor β (TRβ) agonists for the treatment of dyslipidemia.
Shiohara H; Nakamura T; Kikuchi N; Ozawa T; Nagano R; Matsuzawa A; Ohnota H; Miyamoto T; Ichikawa K; Hashizume K
Bioorg Med Chem; 2012 Jun; 20(11):3622-34. PubMed ID: 22542282
[TBL] [Abstract][Full Text] [Related]
12. Ligand induced interaction of thyroid hormone receptor beta with its coregulators.
Valadares NF; Polikarpov I; Garratt RC
J Steroid Biochem Mol Biol; 2008 Dec; 112(4-5):205-12. PubMed ID: 19000767
[TBL] [Abstract][Full Text] [Related]
13. Selective chemical rescue of a thyroid-hormone-receptor mutant, TRbeta(H435Y), identified in pituitary carcinoma and resistance to thyroid hormone.
Hassan AQ; Koh JT
Angew Chem Int Ed Engl; 2008; 47(38):7280-3. PubMed ID: 18683837
[No Abstract] [Full Text] [Related]
14. Thyroid receptor ligands. Part 4: 4'-amido bioisosteric ligands selective for the thyroid hormone receptor beta.
Li YL; Litten C; Koehler KF; Mellström K; Garg N; Garcia Collazo AM; Färnegård M; Grynfarb M; Husman B; Sandberg J; Malm J
Bioorg Med Chem Lett; 2006 Feb; 16(4):884-6. PubMed ID: 16303304
[TBL] [Abstract][Full Text] [Related]
15. In vivo activity of the thyroid hormone receptor beta- and α-selective agonists GC-24 and CO23 on rat liver, heart, and brain.
Grijota-Martínez C; Samarut E; Scanlan TS; Morte B; Bernal J
Endocrinology; 2011 Mar; 152(3):1136-42. PubMed ID: 21239431
[TBL] [Abstract][Full Text] [Related]
16. Design and synthesis of novel 3-hydroxy-cyclobut-3-ene-1,2-dione derivatives as thyroid hormone receptor beta (TR-beta) selective ligands.
Raval S; Raval P; Bandyopadhyay D; Soni K; Yevale D; Jogiya D; Modi H; Joharapurkar A; Gandhi N; Jain MR; Patel PR
Bioorg Med Chem Lett; 2008 Jul; 18(14):3919-24. PubMed ID: 18585912
[TBL] [Abstract][Full Text] [Related]
17. Potential Role of Thyroid Receptor β Agonists in the Treatment of Hyperlipidemia.
Jakobsson T; Vedin LL; Parini P
Drugs; 2017 Oct; 77(15):1613-1621. PubMed ID: 28865063
[TBL] [Abstract][Full Text] [Related]
18. Analysis of the roles of mutations in thyroid hormone receptor-β by a bacterial biosensor system.
Shi C; Meng Q; Wood DW
J Mol Endocrinol; 2014 Feb; 52(1):55-66. PubMed ID: 24174637
[TBL] [Abstract][Full Text] [Related]
19. Structural rearrangements in the thyroid hormone receptor hinge domain and their putative role in the receptor function.
Nascimento AS; Dias SM; Nunes FM; Aparício R; Ambrosio AL; Bleicher L; Figueira AC; Santos MA; de Oliveira Neto M; Fischer H; Togashi M; Craievich AF; Garratt RC; Baxter JD; Webb P; Polikarpov I
J Mol Biol; 2006 Jul; 360(3):586-98. PubMed ID: 16781732
[TBL] [Abstract][Full Text] [Related]
20. Selective Thyroid Hormone Receptor-Beta (TRβ) Agonists: New Perspectives for the Treatment of Metabolic and Neurodegenerative Disorders.
Saponaro F; Sestito S; Runfola M; Rapposelli S; Chiellini G
Front Med (Lausanne); 2020; 7():331. PubMed ID: 32733906
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
